Themis Medicare Limited share price
NSE: THEMISMED · ISIN INE083B01024
Key numbers
- Market cap
- ₹ 1,086 Cr
- Current price
- ₹ 116.93
- 52-week high / low
- ₹ 147 / 65
- Stock P/E
- 27.0
- Book value
- ₹ 43.1
- Dividend yield
- 0.43%
- ROCE
- 2.2%
- ROE
- 0.3%
- Debt to equity
- 0.25
- Sales growth (3 yrs)
- -0.4%
- Profit growth (3 yrs)
- -72.8%
- 1-year return
- -17.5%
About Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It provides active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, anti-emetic, anti-hypertensive, anti-allergic and anti-inflammatory, anti-allergic and appetite stimulant, anticoagulant, antifibrolytic, antimalarial, anti-muscarinic, antioxidant, calcium, cardiovascular, corticosteroid, electrolytes, expectorant, haematinic, hemostatic agent, hemostatic agent with anesthetic, hormones, immunomodulator with anti-viral, muscle relaxant, narcotic analgesic, neuropathy, nutraceuticals, PPI, probiotic, reversal for muscle relaxant, sedatives, skeletal muscle relaxant, skeletal muscle relaxant and analgesic and anti-inflammatory, vasopressors, vitamins, and weight management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai,…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 98 | 78 | 90 | 77 | 87 |
| Operating profit | -10 | -3 | 10 | 4 | -52 |
| Net profit | -14 | -4 | 10 | 9 | 25 |
| EPS (₹) | -1.54 | -0.39 | 1.10 | 0.96 | 2.67 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.